Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

687 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.
Widschwendter M, Rosenthal AN, Philpott S, Rizzuto I, Fraser L, Hayward J, Intermaggio MP, Edlund CK, Ramus SJ, Gayther SA, Dubeau L, Fourkala EO, Zaikin A, Menon U, Jacobs IJ. Widschwendter M, et al. Among authors: fraser l. Lancet Oncol. 2013 Nov;14(12):1226-32. doi: 10.1016/S1470-2045(13)70448-0. Epub 2013 Oct 17. Lancet Oncol. 2013. PMID: 24140203 Free article.
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.
Widschwendter M, Burnell M, Fraser L, Rosenthal AN, Philpott S, Reisel D, Dubeau L, Cline M, Pan Y, Yi PC, Gareth Evans D, Jacobs IJ, Menon U, Wood CE, Dougall WC. Widschwendter M, et al. Among authors: fraser l. EBioMedicine. 2015 Sep 9;2(10):1331-9. doi: 10.1016/j.ebiom.2015.08.037. eCollection 2015 Oct. EBioMedicine. 2015. PMID: 26629528 Free PMC article.
Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening.
Gentry-Maharaj A, Karpinskyj C, Glazer C, Burnell M, Bailey K, Apostolidou S, Ryan A, Lanceley A, Fraser L, Jacobs I, Hunter MS, Menon U. Gentry-Maharaj A, et al. Among authors: fraser l. Climacteric. 2017 Jun;20(3):240-247. doi: 10.1080/13697137.2017.1301919. Epub 2017 Mar 22. Climacteric. 2017. PMID: 28326899 Free PMC article.
Familial ovarian screening--effective or ineffective?
Jacobs IJ, Mackay J, Menon U, Skates SJ, Rosenthal AN, Fraser L. Jacobs IJ, et al. Among authors: fraser l. Br J Cancer. 2006 Oct 23;95(8):1124; author reply 1126-7. doi: 10.1038/sj.bjc.6603407. Br J Cancer. 2006. PMID: 17047658 Free PMC article. No abstract available.
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH, Benjamin E, Singh N, Evans DG, Eccles DM, Skates SJ, Mackay J, Menon U, Jacobs IJ. Rosenthal AN, et al. Among authors: fraser l. J Clin Oncol. 2013 Jan 1;31(1):49-57. doi: 10.1200/JCO.2011.39.7638. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213100 Free PMC article. Clinical Trial.
687 results